Specialist Psychiatry & Psychotherapy, and Neurology
As our Medical Director, Andrei faces the daily challenge to ensure the highest level of clinical care, and to establish and maintain the required quality assurance mechanisms and effective processes of clinical governance. All this and more Andrei masters with a wink and a smile, backed by his extensive clinical and leadership experience in the health care business. He has earned a Master of Business Administration, is a board certified Physician by training in Psychiatry and Psychotherapy as well as in Neurology and in Emergency Medicine. Coupling his passion for clinical work with his interest in medical research, Andrei has contributed to various renowned international journals and numerous congress presentations which consolidated his extensive expertise. When he is not busy managing our clinic, Andrei enjoys listening to the lapping of the waves while manoeuvering his SUP.
Academic career
2018 – Specialist in Psychiatry and Psychotherapy, Bavarian State Medical Association, Germany
2015 – Specialist (FA) in Neurology, Bavarian State Medical Association, Germany
2010 – Doctorate (Dr. med.), Technical University Dresden, Germany
Professional career
Since May 2022: Chief Physician and Member of the Executive Board, NEOVIVA, Vitznau
Since February 2020: Chief Physician and Member of the Executive Board, ANCO Healthcare, Zug
Mar 2020 – Mar 2022: Senior Physician, Deputy Medical Director, Klinik Meissenberg AG, Switzerland
Jan 2019 – Feb 2020: Attending Physician, Crisis Management Department, License to Practice in the Canton of Zug, Klinik Meissenberg AG, Switzerland
May 2017 – Oct 2018: Senior Resident with Personnel Responsibility, Head of the Closed Ward for Addiction Medicine, Clinic and Polyclinic for Psychiatry and Psychotherapy, University of Regensburg, Germany
Selected Publications
- Wirth AM, Johannesen S, Khomenko A, Baldaranov D, Bruun TH, Wendl C, Schuierer G, Greenlee MW, Bogdahn U. Value of fluid-attenuated inversion recovery MRI data analyzed by the lesion segmentation toolbox in amyotrophic lateral sclerosis Journal of Magnetic Resonance Imaging JMRI. 2019 Aug;50(2):552-559. doi: 10.1002/jmri.26577. Epub 2018 Dec 19. PMID: 30569457; PMCID: PMC6767504.
- Wirth AM, Khomenko A, Baldaranov D, Kobor I, Hsam O, Grimm T, Johannesen S, Bruun TH, Schulte-Mattler W, Greenlee MW, Bogdahn U. Combinatory Biomarker Use of Cortical Thickness, MUNIX, and ALSFRS-R at Baseline and in Longitudinal Courses of Individual Patients With Amyotrophic Lateral Sclerosis. Amyotrophic Lateral Sclerosis. Front Neurol. 2018 Jul 30;9:614. doi: 10.3389/fneur.2018.00614. PMID: 30104996; PMCID: PMC6077217
- Baldaranov, Khomenko A, Kobor I, Bogdahn U, Gorges M, Kassubek J, Müller HP. Longitudinal Diffusion Tensor Imaging-Based Assessment of Tract Alterations: An Application to Amyotrophic Lateral Sclerosis. Front Hum Neurosci. 2017 Dec 5;11:567. doi: 10.3389/fnhum.2017.00567. PMID: 29259550; PMCID: PMC5723297.
- Kirzinger L, Khomenko A, Schulte-Mattler W, Backhaus R, Platen S, Schalke B. Myopathy in Childhood Muscle-Specific Kinase Myasthenia Gravis. Pediatric Neurology 2016 Dec;65:90-92.
- Grassinger J, Khomenko A, Hart C, Baldaranov D, Johannesen SW, Mueller G, Schelker R, Schulte-Mattler W, Andreesen R, Bogdahn U. Safety and feasibility of long term administration of recombinant human granulocyte-colony stimulating factor in patients with amyotrophic lateral sclerosis. Cytokine 2014 May;67(1):21-8